Good morning, everyone, and how are you today? If your calendar resembles our own, you may also be gearing up for another round of phone calls, meetings, reading and what-not. It is the middle of the week, after all. To cope, yes, we are brewing that old stand-by - a delicious cup of stimulation. Feel free to join us. By the way, we would like to remind you that we are hosting a webinar on July 19 called '
Getting Off on Off Label.' Here are the details. Meanwhile, here are some tidbits to get you going. Have a great day and stay in touch...Lilly Schizophrenia Drug Fails Late-Stage Trial (Reuters)
J&J And Pfizer Alzheimer Drug Is Seen As A Long Shot (Bloomberg News)
Teva Wins Copaxone Patent Ruling (Globes)
J&J To Pay Up To $300M To Evotec In Diabetes Drug Deal (Pharma Times)
Drugs To Control AIDS May Also Protect The Uninfected (MSNBC)
Glaxo HIV Drug Beats Gilead's Atripla In Study (Reuters)
AstraZeneca Loses Fight Over Generic Seroquel (Courthouse News)
Eisai Breast Cancer Drug Misses Phase III Endpoints (Pharma Times)
Pfizer Refuses To Pay Sewer Taxes To Town (Westchester Patch)
FDA Issues 483 To Exemplar Pharma (Outsourcing Pharma)
EDITOR'S NOTE: Please check this post for updates during the day
tea kettle thx to mirahartford on flickr






4 Comments
For your reading pleasure:
http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM311118.pdf